Fries S - Search Results

1

The cardiovascular pharmacology of COX-2 inhibition.

Fries S, Grosser T. Fries S, et al. Hematology Am Soc Hematol Educ Program. 2005:445-51. doi: 10.1182/asheducation-2005.1.445. Hematology Am Soc Hematol Educ Program. 2005. PMID: 16304418

2

COX-2-derived prostacyclin confers atheroprotection on female mice.

Egan KM, Lawson JA, Fries S, Koller B, Rader DJ, Smyth EM, Fitzgerald GA. Egan KM, et al. Among authors: fries s. Science. 2004 Dec 10;306(5703):1954-7. doi: 10.1126/science.1103333. Epub 2004 Nov 18. Science. 2004. PMID: 15550624

3

Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.

Egan KM, Wang M, Fries S, Lucitt MB, Zukas AM, Puré E, Lawson JA, FitzGerald GA. Egan KM, et al. Among authors: fries s. Circulation. 2005 Jan 25;111(3):334-42. doi: 10.1161/01.CIR.0000153386.95356.78. Epub 2005 Jan 17. Circulation. 2005. PMID: 15655126

4

COX-2-derived prostacyclin modulates vascular remodeling.

Rudic RD, Brinster D, Cheng Y, Fries S, Song WL, Austin S, Coffman TM, FitzGerald GA. Rudic RD, et al. Among authors: fries s. Circ Res. 2005 Jun 24;96(12):1240-7. doi: 10.1161/01.RES.0000170888.11669.28. Epub 2005 May 19. Circ Res. 2005. PMID: 15905461

5

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.

Grosser T, Fries S, FitzGerald GA. Grosser T, et al. Among authors: fries s. J Clin Invest. 2006 Jan;116(1):4-15. doi: 10.1172/JCI27291. J Clin Invest. 2006. PMID: 16395396 Free PMC article. Review.

6

Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2.

Fries S, Grosser T, Price TS, Lawson JA, Kapoor S, DeMarco S, Pletcher MT, Wiltshire T, FitzGerald GA. Fries S, et al. Gastroenterology. 2006 Jan;130(1):55-64. doi: 10.1053/j.gastro.2005.10.002. Gastroenterology. 2006. PMID: 16401468 Clinical Trial.

7

Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans.

Song WL, Wang M, Ricciotti E, Fries S, Yu Y, Grosser T, Reilly M, Lawson JA, FitzGerald GA. Song WL, et al. Among authors: fries s. J Biol Chem. 2008 Jan 11;283(2):1179-88. doi: 10.1074/jbc.M706839200. Epub 2007 Nov 8. J Biol Chem. 2008. PMID: 17993463 Free article.

8

Cyclooxygenase inhibitors repress vascular hyaluronan-synthesis in murine atherosclerosis and neointimal thickening.

Marzoll A, Nagy N, Wördehoff L, Dai G, Fries S, Lindner V, Grosser T, Fischer JW. Marzoll A, et al. Among authors: fries s. J Cell Mol Med. 2009 Sep;13(9B):3713-9. doi: 10.1111/j.1582-4934.2009.00736.x. Epub 2009 Mar 17. J Cell Mol Med. 2009. PMID: 19320776 Free PMC article.

9

Lipoxygenase and prostaglandin G/H synthase cascades in cardiovascular disease.

Zhao L, Grosser T, Fries S, Kadakia L, Wang H, Zhao J, Falotico R. Zhao L, et al. Among authors: fries s. Expert Rev Clin Immunol. 2006 Jul;2(4):649-58. doi: 10.1586/1744666X.2.4.649. Expert Rev Clin Immunol. 2006. PMID: 20477620

10

Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin.

Grosser T, Fries S, Lawson JA, Kapoor SC, Grant GR, FitzGerald GA. Grosser T, et al. Among authors: fries s. Circulation. 2013 Jan 22;127(3):377-85. doi: 10.1161/CIRCULATIONAHA.112.117283. Epub 2012 Dec 4. Circulation. 2013. PMID: 23212718 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters